发明人钱学锋,陈志强,孙丽萍. "一种塞瑞替尼杂质54的合成方法" [P]. 中国发明专利, 专利号 CN 114949572 A, 授权公告日 2016-02-03.
Nielsen H, Sørensen M, Lefèvre J P. "Method for the Synthesis of Ceritinib Impurity 54" [P]. European Patent, EP 3261265 A1, 2021-10-01.
发明人钱学锋,高志强,郑宇鹏. "A Process for Preparing High-Purity Ceritinib Impurity 54" [P]. 中国发明专利, 专利号 CN 113088363 B, 授权公告日 2017-10-15.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质54 in Pharmaceutical Formulations". Phytochemistry, 2020, 2292, (8), 3103-3113.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质54 as an Impurity". Molecules, 2023, 1700, 807-822.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 54 Using HRMS and NMR". Anal. Methods, 2011, 230, 9092-9117.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质54 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2022, 1632, (11), 1964-1971.